China Molybdenum Co Ltd Class A (603993)
Shanghai Stock Exchange · China · prices in CNY · close of 22 Oct 2026
Key indicators
| Last close | CNY 13.85 |
|---|---|
| 52-week range | 13.67 – 28.78 |
| Return, 1 month / 3 months | −22.2% / −29.4% |
| Return, 1 year / 3 years | −10.9% / +157.4% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 56.2% |
| Worst drawdown (1 year) | -48.8% |
| Average daily value traded | 3,582.30M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Molybdenum is a mining company based in Luoyang, in Henan Province, China. It extracts and processes molybdenum and tungsten, and it also operates copper and cobalt mines outside China, including assets in Africa and South America. Its output serves industrial customers such as steel producers and metal processors, who use these metals in alloys, chemicals and other manufactured goods. The company runs mining and processing operations and sells its metal products to buyers in China and overseas markets.
China Molybdenum Co Ltd Class A trades under the code 603993 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Molybdenum Co Ltd Class A (603993) trades on the Shanghai Stock Exchange in China. It last closed at CNY 13.85 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 1,483 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.9% and over the last three months it fell 29.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 29 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.9% | ||
| From 52-week high | -48.8% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -29.4% | ||
| 6-month return | -31.1% | ||
| 12-month return, skipping the last month | 14.6% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.8% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,582.30M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −13.4% |
|---|---|
| 1 month | −22.2% |
| 3 months | −29.4% |
| 6 months | −31.1% |
| 1 year | −10.9% |
| 3 years | +157.4% |
| 5 years | +126.3% |
Signals
| 50-day / 200-day average | 17.91 / 19.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2023 | CNY 0.0851 |
| 7 Jul 2022 | CNY 0.0713 |
| 6 Jul 2021 | CNY 0.0330 |
| 30 Jun 2020 | CNY 0.0430 |
| 28 Jun 2019 | CNY 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.